Global life sciences M&A activity increased by 81% in 2025 to $240 billion, driven by Big Pharma's large-scale deals, despite fewer overall transactions. The surge reflects companies prioritising innovations ready for launch as they face widening growth gaps.
Romanian businesses are facing increased exposure to fiscal and operational risks as customs controls intensify across Europe and nationally, according to EY Romania experts.
More than half of households globally (57%) are worried about annual broadband price increases and think these increases are unfair and unreasonable (60%), according to the latest EY decoding the digital home study.
The EY Entrepreneurship Barometer reveals that 60% of Romanian entrepreneurs plan to invest in innovation, even as 63% consider the business environment unfavourable.
The collaboration aims to address the AI skills gap by helping to equip young people with employable AI experience needed to thrive in the new AI-driven economy.
The lift in M&A activity in 2024 was most pronounced in H2, with 415 deals announced – the highest H2 volume since 2012 and a 58% year-on-year increase from 263 deals in H2 2023.
The current talent landscape is marked by employees moving in short cycles from one employer to another in order to gain new experiences and thus upgrade their skills.
EY Institutional Investor Survey shows that 92% of investors are reluctant to sacrifice short-term gains for the longer-term rewards of ESG investments.
AI is now largely accepted as key to future success in virtually every industry, and it is time for technology companies to translate the potential of AI into performance.
An overwhelming majority of CFOs (87%) believe that generative artificial intelligence (GenAI) will drive efficiency in the tax area, compared to only 15% in 2023.
Electro-Alfa International, a Romanian electrical equipment manufacturer, has announced plans for an Initial Public Offering (IPO) on the Bucharest Stock Exchange (BVB).
Global life sciences M&A activity increased by 81% in 2025 to $240 billion, driven by Big Pharma's large-scale deals, despite fewer overall transactions. The surge reflects companies prioritising innovations ready for launch as they face widening growth gaps.
Romania's Ministry of Finance will conduct its first public offering of Fidelis government bonds for 2026 between January 16 and 23 on the Bucharest Stock Exchange. This marks the 32nd offering since the Fidelis program resumed in July 2020.
Romania's final electricity consumption fell by 0.7% in the first 11 months of 2025 compared to the same period in 2024, according to data published by the National Institute of Statistics (INS).
Romania has the second-lowest consumer prices in the European Union, with costs 36% below the EU average in 2024, according to new Eurostat data released in December 2025.